| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Mar 12, 2024 | Anika Therapeutics, Inc. | CFO | Sell | 42.5 | -5,638 | -4.34% | ✗ | $144.3K |
| Aug 10, 2023 | Aug 11, 2023 | Anika Therapeutics, Inc. | CFO | Sell | 46.3 | -1,133 | -3.30% | ✗ | $21.1K |
| Mar 10, 2023 | Mar 14, 2023 | Anika Therapeutics, Inc. | CFO | Sell | 42.5 | -2,609 | -8.04% | ✗ | $68.1K |
| Mar 9, 2023 | Mar 10, 2023 | Anika Therapeutics, Inc. | CFO | Sell | 46.3 | -1,303 | -5.24% | ✗ | $35.1K |
| Mar 11, 2022 | Mar 14, 2022 | Anika Therapeutics, Inc. | CFO | Buy | 95.0 | +4,000 | 33.55% | ✗ | $98.5K |
| Aug 11, 2021 | Aug 13, 2021 | Anika Therapeutics, Inc. | CFO | Buy | 95.0 | +3,627 | 93.99% | ✗ | $145.8K |
| Feb 27, 2019 | Feb 28, 2019 | INSULET CORP | CFO | Sell | 41.3 | -1,350 | -2.33% | ✓ | $124.2K |
| Feb 22, 2019 | Feb 26, 2019 | INSULET CORP | CFO | Sell | 40.0 | -3,615 | -5.87% | ✗ | $316.7K |
| Feb 14, 2019 | Feb 19, 2019 | INSULET CORP | CFO | Sell | 48.8 | -446 | -0.72% | ✗ | $37.8K |
| May 4, 2018 | May 8, 2018 | INSULET CORP | CFO | Sell | 40.0 | -6,376 | -9.43% | ✗ | $534.8K |
| Feb 24, 2018 | Feb 27, 2018 | INSULET CORP | CFO | Sell | 42.5 | -2,769 | -3.93% | ✗ | $209.2K |
| Feb 22, 2018 | Feb 26, 2018 | INSULET CORP | CFO | Sell | 45.0 | -677 | -0.95% | ✗ | $54.5K |
| May 4, 2016 | May 6, 2016 | INSULET CORP | CFO | Sell | 42.5 | -4,669 | -8.76% | ✗ | $141.2K |